{"disease":{"id":"gd2-antibody-naxitamab","name":"gd2 antibody naxitamab"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06574698","title":"Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma","phase":"","overall_status":"RECRUITING","enrollment_count":64,"lead_sponsor_name":"Guangzhou Women and Children's Medical Center","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}